UC87:LSE:LSE-UBS(Lux)Fund Solutions – MSCI Canada UCITS ETF(hedged GBP)A-acc (GBX)

ETF | Others |

Last Closing

USD 2386.75

Change

0.00 (0.00)%

Market Cap

USD 0.06B

Volume

4.95K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNIF:LSE Xtrackers Nifty 50 Swap UCITS ..

N/A

USD 292,109.69B
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

N/A

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

N/A

USD 701.81B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 636.56B
0R1I:LSE NVIDIA Corp.

N/A

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

N/A

USD 260.39B
0QZO:LSE 0QZO

N/A

USD 258.54B

ETFs Containing UC87:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.41% 64% D 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.41% 63% D 58% F
Trailing 12 Months  
Capital Gain 20.74% 89% A- 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 20.74% 88% B+ 80% B-
Trailing 5 Years  
Capital Gain 72.36% 75% C 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 72.36% 73% C 78% C+
Average Annual (5 Year Horizon)  
Capital Gain 13.15% 72% C 74% C
Dividend Return 13.15% 71% C- 73% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.90% 52% F 69% C-
Risk Adjusted Return 94.58% 85% B 91% A-
Market Capitalization 0.06B 42% F 24% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.